Q&A

Building A New Standard Of CDMO In Fishers, IN: Q&A With Cory Lewis, Founder And CEO

INCOG2

In May of 2022, INCOG BioPharma officially opened its new facility on the northeast side of Indianapolis in Fishers, IN, to support biopharmaceutical companies bringing injectable therapeutics to market. The flexible fill-finish facility, equipped with state-of-the-art equipment, creates a better path to market by combining improved speed, flexibility, risk mitigation, and reduced administrative complexity—enabling biotech and pharmaceutical companies to rapidly scale from clinical to commercial readiness production under one roof.

Cory Lewis, CEO of INCOG Biopharma Services, explains INCOG BioPharma’s rapid growth to deliver customizable and flexible solutions from early development support to commercial filling. INCOG BioPharma’s service offering includes filling drug product into vials, syringes, and cartridges. INCOG also offers support services to include formulation development, analytical development, stability testing and storage, and final inspection, labeling, packaging, and device assembly.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma